Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 93Leukemia 70Lymphoma 52Leukemia, Myeloid, Acute 41Burkitt Lymphoma 36Myelodysplastic Syndromes 32Lymphoma, Non-Hodgkin 27Hodgkin Disease 27Lymphoma, Mantle-Cell 24Leukemia, Lymphocytic, Chronic, B-Cell 23Recurrence 21Lymphoma, Large B-Cell, Diffuse 21Graft vs Host Disease 21Lymphoma, Follicular 19Congenital Abnormalities 18Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 17Multiple Myeloma 17Leukemia, Myeloid, Accelerated Phase 16Leukemia, Myelogenous, Chronic, BCR-ABL Positive 16Myeloproliferative Disorders 15Leukemia, Myelomonocytic, Chronic 15Blast Crisis 15Lymphoma, B-Cell, Marginal Zone 14Leukemia, Myeloid, Chronic-Phase 13Lymphoma, Large-Cell, Immunoblastic 12Hematologic Neoplasms 12Primary Myelofibrosis 11Lymphoma, Large-Cell, Anaplastic 11Breast Neoplasms 11Neoplasms, Plasma Cell 10

Interventions

Gemcitabine 43pembrolizumab 36Paclitaxel 36Nivolumab 31Docetaxel 29Capecitabine 29Bevacizumab 29Oxaliplatin 28Fluorouracil 28Cisplatin 26Leucovorin 24Cyclophosphamide 23Radiosurgery 20Irinotecan 20Carboplatin 20aldesleukin 19Cetuximab 19Interleukin-2 16fludarabine phosphate 15fludarabine 15Pemetrexed 15Trastuzumab 14Magnetic Resonance Spectroscopy 14Ipilimumab 14Fulvestrant 14130-nm albumin-bound paclitaxel 14Prednisone 13Everolimus 13Radiotherapy 12Panitumumab 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Neoplasm Metastasis × Methotrexate × Clear all
NCT00001880 2021-11-10

Stem Cell Transplantation for Metastatic Solid Tumors

National Institutes of Health Clinical Center (CC)

Phase 2 Terminated
42 enrolled 11 charts

Graft vs Host Disease, Neoplasm Metastasis, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡